Serial Number 79260400
Registration 5917444
700

Registration Progress

Application Filed
Mar 16, 2019
Under Examination
Approved for Publication
Sep 10, 2019
Published for Opposition
Sep 10, 2019
Registered
Nov 26, 2019

Attorney Assistance

Section 8 (6-Year) Declaration Due (Based on registration date 2019-11-26)
Due: Nov 26, 2025 140 days

Basic Information

Serial Number
79260400
Registration Number
5917444
Deadline
November 26, 2025
Description
5 Year - Section 71 and 15 Renewal
Filing Date
March 16, 2019
Registration Date
November 26, 2019
Published for Opposition
September 10, 2019
Drawing Code
2

Status Summary

Current Status
Active
Status Code
700
Status Date
Nov 26, 2019
Registration
Registered
Classes
042

Rights Holder

Boehringer Ingelheim International GmbH

27
Address
55218 Ingelheim
DE

Ownership History

Boehringer Ingelheim International GmbH

Original Applicant
27
55218 Ingelheim DE

Boehringer Ingelheim International GmbH

Owner at Publication
27
55218 Ingelheim DE

Boehringer Ingelheim International GmbH

Original Registrant
27
55218 Ingelheim DE

Legal Representation

Attorney
Martin J. Beran

USPTO Deadlines

Next Deadline
140 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2019-11-26)
Due Date
November 26, 2025
Grace Period Ends
May 26, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

24 events
Date Code Type Description
Nov 26, 2024 REM3 E COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Apr 3, 2020 FINV P FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 14, 2020 FICS P FINAL DISPOSITION NOTICE SENT TO IB
Mar 14, 2020 FIMP P FINAL DISPOSITION PROCESSED
Feb 26, 2020 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 26, 2019 R.PR A REGISTERED-PRINCIPAL REGISTER
Sep 10, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 10, 2019 PUBO A PUBLISHED FOR OPPOSITION
Aug 21, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 3, 2019 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 3, 2019 ALIE A ASSIGNED TO LIE
Jul 25, 2019 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 19, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 19, 2019 RFNT P REFUSAL PROCESSED BY IB
Jul 18, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 18, 2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 2, 2019 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 2, 2019 RFRR P REFUSAL PROCESSED BY MPU
Jun 18, 2019 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 18, 2019 MAFR O APPLICATION FILING RECEIPT MAILED
Jun 17, 2019 CNRT R NON-FINAL ACTION WRITTEN
Jun 12, 2019 DOCK D ASSIGNED TO EXAMINER
Jun 12, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 6, 2019 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB

Detailed Classifications

Class 042
Medical and scientific research in the field of immunology, oncology and immuno-oncology; providing medical and scientific research information in the field of immunology, oncology and immuno-oncology

Additional Information

Design Mark
The mark consists of stripes forming an arrow pointing left. From left to right, the first two stripes are dark orange, the next three stripes are orange and the last three stripes are light orange.
Color Claim
The color(s) light orange, orange and dark orange is/are claimed as a feature of the mark.

Classification

International Classes
042